Just received an email from Simply Wall St in regard Friday's trading report heading "New major risk - Financial position , reads " The company has less than than a year of cash runaway based on its current free cash flow trend . Fresh cash flow - AUS $36 m This is considered a major risk . With less than a year's worth of cash the company will need to raise capital or take debt unless cash flow improves . This would dilute existing shareholders or increase balance sheet risk . Currently the following risks have been identified for the company . Major risk . Less than a year of runaway based on free cash flow trend (Aus $ 36 m free cash flow). Minor Risk . Currently unprofitable and not forecast to be able to become profitable profitable over the next two years . " This is what has been concerning me ( my last post ) " Company not expected to be profitable minimum 2 maybe 3 years , company reliant on its shareholders most at risk common shareholders us unsecured expected to carry / support management . " Can see a another capital raising coming up with our present management team just as we did back then when we copped capital raising from the last lot when we purchased a truck of generic rubbish off Teva .
- Forums
- ASX - By Stock
- What MYX chart shouts
MYX
mayne pharma group limited
Add to My Watchlist
1.92%
!
$5.32

Just received an email from Simply Wall St in regard Friday's...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.32 |
Change
0.100(1.92%) |
Mkt cap ! $429.7M |
Open | High | Low | Value | Volume |
$5.29 | $5.34 | $5.15 | $624.5K | 118.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 137 | $5.64 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.05 | 506 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 5.320 |
9 | 2504 | 5.310 |
3 | 2698 | 5.300 |
2 | 1464 | 5.290 |
2 | 28609 | 5.280 |
Price($) | Vol. | No. |
---|---|---|
5.340 | 8548 | 5 |
5.350 | 30430 | 4 |
5.360 | 100 | 1 |
5.370 | 1756 | 2 |
5.380 | 75 | 1 |
Last trade - 15.59pm 18/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online